Technetium -99m is an isomer of technetium 99, which is used in nuclear medicine and the precursor for technetium-99 is molybdenum-99, a radioactive nuclei generally produced in reactors. Technetium-99m is used as a radioactive tracer and can be detected in the body by equipment such as gamma cameras, as Tc-99m emits gamma rays. Technetium-99m, in the form of sodium pertechnetate (Na99mTcO4), is easily obtained from a 99Mo99mTc generator. Sodium Pertechnetate Tc 99m Injection is used in adults as an agent for thyroid imaging, salivary gland imaging, urinary bladder imaging (direct isotopic cystography) for the detection of vesico-ureteral reflux, coronary artery disease, and nasolacrimal drainage system imaging. Technetium-99m (Tc-99m) is frequently utilized in nuclear medicine imaging techniques. Due to its short half-life, it may be administered to patients safely while lowering radiation exposure. In the Middle East and other parts of the world, tc-99m is often utilized for a variety of diagnostic procedures, including cardiac perfusion imaging, bone scans, lung scans, and others.
Market Dynamics
High prevalence of congenital heart disease among individuals with Down syndrome is expected to propel the growth of the MEA technetium-99m market over the forecast period. For instance, in November 2022, National Center for Biotechnology Information published data according to which during the year 2016 to 2020 the prevalence of congenital heart disease in subjects with Down Syndrome in the Kingdom of Saudi Arabia and showed a prevalence of 66.1% (95% CI: 57.2% to 74.5%). Down syndrome is a key factor in morbidity and early death in these individuals with congenital heart diseases.
Key features of the study:
Detailed Segmentation:
Table of Contents
*Browse 27 market data tables and 21 figures on "MEA Technetium-99m Market” - forecast to 2030
Joining thousands of companies around the world committed to making the Excellent Business Solutions.
View All Our Clients